|

Selnoflast Clinical Trials

1 actively recruiting trial across 1 location

Also known as: RO7486967

Pipeline

Phase 2: 1

Top Sponsors

  • Genentech, Inc.1

Indications

  • Heart Disease1
  • Atherosclerosis1

Beverly Hills, California1 trial

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

Cardiovascular Research Foundation of Southern California

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.